Sarepta Therapeutics Inc (SRPT)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 3,073,460 2,685,370 2,683,640 2,464,860 2,579,330 2,450,850 2,472,610 2,488,380 2,557,860 2,625,930 2,469,300 2,530,950 2,604,100 2,185,310 2,265,220 2,271,350 2,485,200 2,322,670 2,459,420 2,547,350
Total current liabilities US$ in thousands 731,684 699,489 688,490 608,709 653,659 450,743 498,654 536,884 619,604 602,916 545,566 454,962 452,733 373,443 425,022 364,736 416,026 378,388 354,896 306,429
Current ratio 4.20 3.84 3.90 4.05 3.95 5.44 4.96 4.63 4.13 4.36 4.53 5.56 5.75 5.85 5.33 6.23 5.97 6.14 6.93 8.31

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,073,460K ÷ $731,684K
= 4.20

The current ratio of Sarepta Therapeutics Inc has shown a decreasing trend from March 31, 2020, where it was 8.31, to December 31, 2024, where it stood at 4.20. This indicates a potential liquidity risk as the company's ability to cover its short-term obligations with its current assets has declined over the period. While a current ratio above 1 is generally considered healthy, the downward trend suggests a decreasing ability to meet short-term liabilities with current assets. It would be prudent for stakeholders to closely monitor this ratio and assess the company's liquidity position carefully.